Magnetic Resonance Imaging-guided Online Adaptive Radiotherapy of Pelvic Lymph Node Metastases

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 16, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

July 31, 2028

Conditions
Pelvic and Para-aortic Lymph Node Metastases
Interventions
RADIATION

Magnetic resonance Imaging-guided online adaptive radiotherapy

On each day of treatment, a new MRI scan in the treatment position will be acquired using the dedicated MR simulator, co-registered with the original one. The original target and organ at risk (OAR) contours will be propagated to the new image set using rigid and deformable image registration. The contours will be adapted to changes detected with MRI of the day. The original SBRT treatment plan will be adapted to the changed and hence adapted anatomy of targets and OARs by plan optimization. Dose calculation will be performed on the newly generated synthetic CT (preferred) or, if there is a contra-indication for synthetic CT, on the original image.

Trial Locations (1)

8091

RECRUITING

Zurich University Hospital, Department of Radiation Oncology, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT07083648 - Magnetic Resonance Imaging-guided Online Adaptive Radiotherapy of Pelvic Lymph Node Metastases | Biotech Hunter | Biotech Hunter